What is NVAX's current stock price?

As of now, NVAX is trading at $6.47, with a daily change of +3.94%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

NVAX Stock Analysis & IQ Rating | Novavax

NVAX

Novavax

$6.47

+$0.25 | +3.94%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$11.5

MKT CAP

$1.05B

52W Low

$5.01

VOL

$3.99M

P/E Ratio

3.6

AVG VOL

$4.49M

RSI

32.34

TREND

Downtrend

NVAX Stock IQ

Login to see Novavax (NVAX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NVAX Target Price

Login to display

Strengths

NVAX Rewards

Earnings are forecast to grow

Chart

$8.52 (-24.06%)

$7.47 (-13.39%)

$6.8 (-4.85%)

$8.94 (-27.63%)

1year

6month

3month

1month

NVAX Risk Level

NVAX has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

NVAX Analysts Opinion

NVAX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

NVAX Analysts Opinion

NVAX Analysts opinion is positive but there was a setback from the past 3 months

NVAX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

100%

NVAX Street Sentiment

NVAX Street Sentiment is extremely bullish and have positive views on the near-term outlook

NVAX Performance Sentiment

Sentiments overview associated with NVAX events and the stock performance.

80%

14%

Positive

Negative

28 out of 35
events present

5 out of 35
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$6.97

Resistance
Price

$6.97

Current Price Range

$9.55

Show methods +

Linked to NVAX

IQ

Close Price

Change

MRNA

3.62

23.72

+6.08%

NVAX Latest Analysis +

Novavax rises after a seven-day slide.

Fri Nov 21, 2025

$6.47 | +3.94%

Momentum

Notable Wednesday Option Activity: NVAX BLK MP. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Novavax Inc. (Symbol: NVAX) where a total volume of 22231 contracts has been traded thus far today a contract volume which is representative of approximately

Wed Nov 19, 2025

$6.34 | -3.50%

Momentum

Novavax Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript.

Wed Nov 19, 2025

$6.34 | -3.50%

Activity

JP Morgan Maintains Novavax (NVAX) Underweight Recommendation. Fintel reports that on November 18 2025 JP Morgan maintained coverage of Novavax (NasdaqGS:NVAX) with a Underweight recommendation. Analyst Price Forecast Suggests 104.38% Upside

Wed Nov 19, 2025

$6.34 | -3.50%

Potential

Rating

Oversold Conditions For Novavax (NVAX). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Fri Nov 14, 2025

$6.97 | -1.27%

Technical

Novavax Q3 Earnings & Revenues Beat Estimates 25 Sales View Raised. NVAX exceeds third-quarter expectations boosted by a Sanofi milestone payment. It lifts its 2025 sales outlook.

Fri Nov 7, 2025

$7.44 | -1.98%

Earnings

Novavax Inc. (NASDAQ:NVAX) Q3 2025 Earnings Call Transcript. Novavax Inc. (NASDAQ:NVAX) Q3 2025 Earnings Call Transcript November 6 2025 Novavax Inc. misses on earnings expectations. Reported EPS is $-1.24654 EPS expectations were $-1.08. Operator: Good morning and welcome to Novavax’.s Third Quarter 2025 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note this event is being recorded and I would now [….]

Fri Nov 7, 2025

$7.44 | -1.98%

Earnings

Novavax outlines $1.04B–$1.06B 2025 revenue framework and targets non-GAAP profitability as early as 2028 amid partnership-driven transition.

Thu Nov 6, 2025

$7.59 | -1.30%

Activity

Novavax GAAP EPS of -$1.25 misses by $0.33 revenue of $70.45M beats by $25.58M.

Thu Nov 6, 2025

$7.59 | -1.30%

Earnings

Earnings Snapshot: Novavax beats Q3 revenue estimates but misses on profit. raises FY revenue outlook.

Thu Nov 6, 2025

$7.59 | -1.30%

Earnings

Potential

FAQ About NVAX Stock Insights

What is NVAX current stock price?

What are NVAX stock strengths?

What is NVAX Risk Level?

What is NVAX market cap and volume?

What is NVAX current Stock IQ?

Should I buy NVAX stock right now?

Is NVAX a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVAX?

What does a 'Strong Sell' rating mean for NVAX?

What factors influence NVAX's Stock IQ?

Explore our NVAX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored NVAX Stock Strategies
Effective Risk Management

FIND US ON

Receive our NVAX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

NVAX

Novavax

Current Price

$6.47

+$0.25 | +3.94%

52W High

$11.5

MKT CAP

$1.05B

52W Low

$5.01

VOL

$3.99M

P/E Ratio

3.6

AVG VOL

$4.49M

RSI

32.34

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

NVAX Rewards

Earnings are forecast to grow

Linked to NVAX

Symbol

IQ

Close

Change

MRNA

3.62

23.72

+6.08%

NVAX Stock IQ

Login to unlock Novavax (NVAX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$8.52 (-24.06%)

$7.47 (-13.39%)

$6.8 (-4.85%)

$8.94 (-27.63%)

1year

6month

3month

1month

NVAX Analysts Opinion

NVAX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

NVAX Analysts Opinion

NVAX Analysts opinion is positive but there was a setback from the past 3 months

NVAX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

100%

NVAX Street Sentiment

NVAX Street Sentiment is extremely bullish and have positive views on the near-term outlook

NVAX Risk Level

NVAX has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

NVAX Performance Sentiment

Sentiments overview associated with NVAX events and the stock performance.

80%

14%

Positive

Negative

28 out of 35
events present

5 out of 35
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$6.97

Resistance
Price

$6.97

Current Price Range

$9.55

Show methods +

NVAX Latest Analysis

Novavax rises after a seven-day slide.

Fri Nov 21, 2025

$6.47 | +3.94%

Momentum

Notable Wednesday Option Activity: NVAX BLK MP. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Novavax Inc. (Symbol: NVAX) where a total volume of 22231 contracts has been traded thus far today a contract volume which is representative of approximately

Wed Nov 19, 2025

$6.34 | -3.50%

Momentum

Novavax Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript.

Wed Nov 19, 2025

$6.34 | -3.50%

Activity

JP Morgan Maintains Novavax (NVAX) Underweight Recommendation. Fintel reports that on November 18 2025 JP Morgan maintained coverage of Novavax (NasdaqGS:NVAX) with a Underweight recommendation. Analyst Price Forecast Suggests 104.38% Upside

Wed Nov 19, 2025

$6.34 | -3.50%

Potential

Rating

Oversold Conditions For Novavax (NVAX). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Fri Nov 14, 2025

$6.97 | -1.27%

Technical

Novavax Q3 Earnings & Revenues Beat Estimates 25 Sales View Raised. NVAX exceeds third-quarter expectations boosted by a Sanofi milestone payment. It lifts its 2025 sales outlook.

Fri Nov 7, 2025

$7.44 | -1.98%

Earnings

Novavax Inc. (NASDAQ:NVAX) Q3 2025 Earnings Call Transcript. Novavax Inc. (NASDAQ:NVAX) Q3 2025 Earnings Call Transcript November 6 2025 Novavax Inc. misses on earnings expectations. Reported EPS is $-1.24654 EPS expectations were $-1.08. Operator: Good morning and welcome to Novavax’.s Third Quarter 2025 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note this event is being recorded and I would now [….]

Fri Nov 7, 2025

$7.44 | -1.98%

Earnings

Novavax outlines $1.04B–$1.06B 2025 revenue framework and targets non-GAAP profitability as early as 2028 amid partnership-driven transition.

Thu Nov 6, 2025

$7.59 | -1.30%

Activity

Novavax GAAP EPS of -$1.25 misses by $0.33 revenue of $70.45M beats by $25.58M.

Thu Nov 6, 2025

$7.59 | -1.30%

Earnings

Earnings Snapshot: Novavax beats Q3 revenue estimates but misses on profit. raises FY revenue outlook.

Thu Nov 6, 2025

$7.59 | -1.30%

Earnings

Potential

Discover NVAX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVAX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our NVAX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVAX Stock trends

NVAX Stock performance

NVAX Stock analysis

NVAX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVAX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVAX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

NVAX Stock Analysis & IQ Rating | Novavax

NVAX Stock IQ

NVAX Target Price

NVAX Risk Level

NVAX Analysts Opinion

NVAX Street Sentiment

NVAX Performance Sentiment

Technical Price Levels

Explore our NVAX Stock insights

Receive our NVAX Daily Alerts

NVAX Stock IQ

NVAX Street Sentiment

NVAX Risk Level

Technical Price Levels

Discover NVAX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVAX. We're here to help you make informed investment decisions today.

Receive our NVAX Daily Alerts

NVAX Runner Alarm